Xarelto Claims to be Heard in Coming Year Through Bellwether Trials
- Last Updated: August 4th, 2023
Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
Fact-Checked
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Xarelto Claims to be Heard in Coming Year Through Bellwether Trials
According to the Louisiana Record, over 9,000 Xarelto claims have been brought across the U.S. against the makers and distributors of the anticoagulant drug Xarelto, the majority centralized in multidistrict litigation (MDL) in the Eastern District of Louisiana under U.S. District Court Judge Eldon Fallon.
Another 1,000 cases have been filed in state court in Philadelphia, Pennsylvania, and an additional 1,000 are pending in Delaware.
Table of Contents
Judge Chooses Four Xarelto Claims to Push Through the Bellwether Trial Process
Judge Fallon has picked four Xarelto claims to serve as bellwether lawsuits from the MDL to be tried during 2017.
These include:
- The first case, scheduled for February 2017, involves a Louisiana man who alleges that he suffered severe gastrointestinal bleeding after using Xarelto.
- The second lawsuit to be tried in Louisiana has been brought by the husband of a woman who died from a brain hemorrhage approximately one month after she began taking Xarelto.
- The third trial, which will be held in Mississippi, relates to a woman who claims to have suffered intestinal bleeding after using Xarelto to treat blood clots.
- The fourth case involves a Texas man who died due to gastrointestinal bleeding resulting from the use of Xarelto.
Although the results of these bellwether cases are not binding on the other Xarelto lawsuits in the MDL, they will likely set the tone for the Xarelto Case as a whole and settlement discussions, and be used to help determine whether a settlement can be reached.
If no settlement is possible or the defendants are determined to be entirely at fault, the cases may be sent back to their home districts.
The defendants in the Xarelto cases are German drug maker Bayer AG and its U.S. distributor, Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson.
Xarelto Claims Result From Over 10,000 Reported Adverse Event
According to a report released in July 2016 by the Institute for Safe Medication Practices (ISMP), there was a total of 10,674 adverse event reports associated with Xarelto in 2015, including 1,121 patient deaths and 4,508 injuries that required hospitalization.
The most common reports were of bleeding on the brain and in the intestines.
Xarelto Claims to be Heard in Coming Year Through Bellwether Cases will be updated as the Xarelto lawsuits move forward.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
